(TheNewswire)Vancouver, Canada – July 30, 2026 - TheNewswire – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H, WKN: A3EKSZ) ("Onco" or the "Company”) is pleased to announce, further to its news release dated June 30, 2026, progress with respect to its collaborative polymer…
Austin, Texas, July 30th, 2026, FinanceWireThis article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising.Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) announced the closing of its previously announced non-brokered private placement with Sorbie Bornholm…
(TheNewswire)Vancouver, Canada – July 27, 2026 – TheNewswire - Onco-Innovations Limited (CBOE: ONCO) (“Onco” or the “Company”) announces that, further to its previously announced non-brokered private placement financing representing a notional subscription amount of approximately CAD$5,000,000 (the…
Austin, Texas, July 24th, 2026, FinanceWireDisseminated on behalf of Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) and may include paid advertising.Cancer treatment is undergoing one of its most significant transformations in decades. Rather than relying on the traditional “one drug fits…
(TheNewswire)Vancouver, Canada – July 16, 2026 – TheNewswire - Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H, WKN: A3EKSZ) ("Onco" or the "Company”) announces, further to its news release dated May 8, 2026, the initiation of key absorption, distribution, metabolism and exc…
Austin, Texas, July 14th, 2026, FinanceWireThis article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising.Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) announced the successful completion of its analytical reference standard preparation program for A83B4…
